Dermatology & Inflammatory Disease
Hidradenitis Suppurativa Clinical Research
Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that causes painful nodules, abscesses, and recurring lesions that can significantly impact quality of life. CenExel partners with sponsors to advance innovative HS therapies through expert-led clinical research, patient-focused care, and access to diverse study populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Hidradenitis Suppurativa Research
CenExel provides specialized clinical trial support for Hidradenitis Suppurativa research through experienced investigators, advanced operational infrastructure, and patient-centered recruitment strategies. Our multidisciplinary teams help sponsors accelerate study timelines while maintaining scientific excellence from first-patient-in through study completion.
Conditions Covered
Hidradenitis Suppurativa Conditions We Research
Our dermatology research sites support a broad range of inflammatory and chronic skin conditions related to Hidradenitis Suppurativa and associated disorders.
- Moderate to Severe Hidradenitis Suppurativa
- Recurrent HS Flare-Ups
- Inflammatory Skin Lesions
- Chronic Abscesses
- Pain Associated with HS
- HS with Metabolic Syndrome
- HS in Adolescent Patients
- Dermatologic Inflammatory Disorders
Our Approach
Why Sponsors Choose CenExel for HS Research
CenExel delivers specialized expertise for Hidradenitis Suppurativa clinical trials through experienced investigators, strong recruitment strategies, and operational excellence designed to support successful outcomes.
01
Expert Dermatology Teams
Our experienced investigators and coordinators specialize in inflammatory skin disease research and patient-centered care.
02
Diverse Patient Recruitment
Access to broad and diverse patient populations helps support efficient enrollment and representative study data.
03
Advanced Clinical Infrastructure
Integrated clinical systems and experienced operational teams ensure efficient trial execution.
04
High-Quality Trial Execution
From startup through closeout, our teams maintain operational excellence and data quality across every study phase.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase Hidradenitis Suppurativa clinical research, from proof-of-concept studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Dermatology Task Force
CenExel supports dermatology-focused clinical trials with experienced investigators, centralized operational support, and access to diverse patient populations across multiple research sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
